ImmunoGen Competitors and Similar CompaniesClear all
Puma Biotechnology's competitors and similar companies include Immunomedics and Ablynx.
 Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2010 | Founding Date 1982 | Founding Date 2001 |
Type | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||
Locations | Locations Los Angeles, US HQ | Locations Morris Plains, US HQ | Locations Gent, BE HQ |
Employees | Employees 27214% decrease | Employees 8914% decrease | Employees 1252% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $228.4m (FY, 2025) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) €85.2m (FY, 2016) |
Cost of goods | Cost of goods $58.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $170.2m (FY, 2025) | Gross profit $295k (FY, 2019) | Gross profit N/A |
Net income | Net income N/A | Net income ($357.3m) (FY, 2019) | Net income (€1.1m) (FY, 2016) |
Operating ⚠ | |||
Patents (US) | Patents (US) N/A | Patents (US) 405 (Sep, 2022) | Patents (US) 50 (Q2, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 30m | Total funding raised $ 498.8m |
For sources of this data, please see the company profile
View Company Profiles
Immunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View companyAblynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View company